Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial

Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review

(2018) Masato Ishida et al.   Modern Rheumatology

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

(2017) Peter C. Taylor et al.   NEW ENGLAND JOURNAL OF MEDICINE

A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective

(2016) Peter C. Taylor et al.   RHEUMATOLOGY INTERNATIONAL

Remaining Pain in Early Rheumatoid Arthritis Patients Treated With Methotrexate

(2016) Reem Altawil et al.   ARTHRITIS CARE & RESEARCH

Non-inflammatory Causes of Pain in Patients with Rheumatoid Arthritis

(2016) Sean D. Boyden et al.   Current Rheumatology Reports

Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism

(2015) Gustaf Wigerblad et al.   ANNALS OF THE RHEUMATIC DISEASES

Patient Perceptions concerning Pain Management in the Treatment of Rheumatoid Arthritis

(2013) P Taylor et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multina

(2012) F. Tubach et al.   ARTHRITIS CARE & RESEARCH

Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development

(2012) Andrew D Cook et al.   ARTHRITIS RESEARCH & THERAPY

Central Sensitization in Patients with Rheumatoid Arthritis: A Systematic Literature Review

(2011) Mira Meeus et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)

(2009) J Augustsson et al.   ANNALS OF THE RHEUMATIC DISEASES

JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat

(2008) Elisa Dominguez et al.   JOURNAL OF NEUROCHEMISTRY

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

(2007) Robert H. Dworkin et al.   JOURNAL OF PAIN